Viewing Study NCT03353857


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-01-03 @ 10:20 PM
Study NCT ID: NCT03353857
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2017-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module